Latest News

The relevance of social media monitoring and engagement in the healthcare industry

Billions of conversations take place every month on social media platforms including Twitter, Facebook, Instagram, as well as blogs and forums. These conversations are not only taking place in social settings, but are influencing companies as well. Social media use continues to rise as we see more people using it in both their personal and professional lives — and brands are responding by continually looking for better ways to engage with them. All of these conversations comprise pools of rich data, but listening to them for meaning can be challenging. So, how do companies make sense of all this endless data to determine how and where to listen, identify what consumers are talking about, classify the types of content they are posting and understand the behaviors they are engaging in?

In the healthcare industry, patients and healthcare providers (HCPs) are looking to social media for information and support regarding their health and the health of their patients. They serve as a “perpetual focus group,” whose conversations taking place on social media provide brands with the opportunity to listen. Patients share their opinions, ask questions about diseases and treatment options, and directly or incidentally report adverse events. Meanwhile, HCPs voice opinions on the healthcare industry, provide thought leadership on a wide range of topics such as participatory medicine, reimbursement, and medical education. In a recent survey, more than 40 percent of respondents reported that information found via social media would affect the way they coped with a chronic condition or their approach to diet and exercise; 34 percent said it would affect taking certain medication.¹ This demonstrates to companies that patients are directly impacted by what they view on social media and in order for brands to leverage that data radiating out of all the social conversations, several factors need to be in place.

When determining how to utilize the data in social media conversations, one rule-of-thumb is to work backward — start with objectives and determine which categories of data would support the analysis and provide actionable insights. Companies can build a tagging structure based on relevant categories, such as: source (e.g., social media platform), author, type, topic, behavior, and sentiment. For example, if a brand is looking to identify who is talking about a product, the kinds of content they are posting, and the topics within their content, a structure that would classify posts into categories such as Consumer, Branded Product, and Medical Inquiry could be utilized. As more and more posts are tagged, patterns, trends, and themes can be identified.

Social media strategists must be cognizant of the regulations pharmaceutical companies face when approaching social media usage and determining involvement. Many pharmaceutical companies have legitimate concerns regarding social media participation, including the need to have:

• Identification, triaging, and reporting of Adverse Events (AEs), Product Quality Complaints (PQCs)
• Consistency of messaging and having a team that can adhere to social media promotion guidelines and regulations
• Previous experience and internal knowledge in terms of social media engagement and usage

The current regulatory environment is understandably daunting and serious consideration must be applied when developing a social strategy. While these challenges exist today and are likely to remain for the foreseeable future, there are prescriptive solutions and industry best practices available to mitigate risk.  Regulations and the strategies that come about as a result can impact a pharmaceutical company’s ability to continue that social media conversation. Reliable processes can be implemented, borrowing best practices from existing patient interaction policies, as well as social monitoring and engagement strategies from other regulated industries.

Other key steps and factors to consider to successfully make sense of social conversations include:

• Train staff – Reduce risk by utilizing highly trained specialists experienced in the nuance of monitoring, identifying, and triaging AEs.
• Establish documented workflows – Configure a systematic approach to the identification of AEs and PQCs and their triaging to the appropriate Pharmacovigilance point-of-intake.
• Technology – Utilize cutting-edge technology platforms to monitor and tag conversations. Although there is no replacement for human engagement, as volume scales, technology becomes increasingly critical for success.

The importance of listening is always stressed in the pharmaceutical industry, but the actual work requires an appreciation of how different people “speak” on social media (patients versus HCPs), understanding the value of categorical organization of data, and the selection and application of appropriate technology. There is no silver bullet, but building meaningful structures out of disparate sets of data is doable – in fact, it’s necessary if the industry is to make the most out of today’s social media landscape. Leveraging social media data and engagement opportunities are crucial imperatives for companies to support key business goals focused around patient and provider programs — and it will pay off.

Reference

1. Social Media ‘Likes’ Healthcare: From Marketing to Social Business. PWC Health Research Institute. April 2012

Healthcare is the most personal of categories, and the micro-/macro-economic benefits of addressing individual patient needs and barriers at population-level scale are huge. Digital marketers from the early 2000s will remember the earliest pushes into personalization – most efforts were not successful. But a lot has changed, especially in the past year. A new generation of multi-channel marketing (MCM) is coming – one that successfully merges time-tested crafts of traditional digital, direct, and RM with rationalized people-based marketing enabled by ad-tech and CRM automation.

We see 2016 marking the turning point in our ability to orchestrate a direct, personal customer interaction in a logical, spontaneous sequence, that is automated and in real time. The results we’re seeing are positive – lifts in ROI as high as 5-10% across industry groups, as well as higher engagement rates, lower media costs, more scalable revenue and profits, better health outcomes, and a rich proprietary data trove that drives the single-most-important source of competitive advantage today – customer relationships.

MCM transformation must now move beyond the incremental. Bigger value creation will be architected through connected journeys where segmented, personalized game plans automate a range of individual addressable opportunities. These media investments won’t necessarily show up on Kantar, so competitive intelligence will be harder to glean going forward. Companies should look both ahead and laterally in their MCM maturity curve to create disproportionate value. For example, digital-centric brands pushing forward with personalization may look to drive greater scale and cultural relevance via traditional DTC and pilot addressable video. HCP-sales-focused organizations should better integrate the consumer/ patient influence models and direct relationships. DTC-focused brands who lack time to master search and content marketing can demonstrate digital halo to secure funding for automation initiatives. Despite this great diversity and range of motion, most firms have to create greater value. Here are four developments I would emphasize to drive continued MCM maturity in 2016:

1. Prioritize Addressable Media in the MCM Playbook

Personalization is the pinnacle of people-based marketing. It relies on the fact that addressability, the ability to target an individual and create a tailored event stream at scale, is increasing volumetrically across all of the people-based platforms we work with every day, including Facebook, Google, Amazon, and many more. As the agenda and role of the consumer are changing rapidly, marketers have to personalize the way we speak to our audiences.

The good news is that personalization in healthcare can be accomplished in lots of different ways with different levels of effort and risk thresholds. Consider some of these as entry points:

• Personalized marketing materials include different treatments and offers – or the copy, creative (imagery), and calls to action – based on the recipient
• Personalized content provides specific materials that are relevant to the individual based on preference data, medical specialty, condition,  demographic data, or based on key terms that the individual provides
• Preference personalization is when healthcare companies enable their consumers to select product options and manage desired interactions

2. Accelerate Strategic Planning Cycles via Real-Time Analytics

The prediction for 2016 is that advanced analytics, with more powerful campaign platforms like Adobe Workbench, will continue to become mainstream, particularly to inform how customer strategies drive the overarching business strategy at the enterprise level. Traditional analytics teams working towards monthly reports could not, and cannot, operate in real time. Now, real-time reporting requires faster synthesis and strategy planning oversight. Whether you’re in CPG, financial services, entertainment, or healthcare, all marketing game plans are learning to operate in more real-time environments. Thus, customers’ immediate needs, behaviors, and values can be served in the instantaneous moment of truth. Speed to insight is the new source of competitive advantage in increasingly crowded marketplaces.

3. Increase Adoption of Next Generation of Immersive Media

We will see further convergence between the addressable digital, virtual world and the real world. You must collapse the physical and temporal distance between your customers and the brand while inserting the brand into both prescriptive and spontaneous journey maps in unique relevant ways. The power of both addressable and more immersive media, including live human-to-human interaction, and supportive content marketing will increasingly simulate and unlock steps towards the real life health experience. Journey mapping will focus more on connective experience design across advertising and augmented care delivery, creating highly experiential value chains that are more immersive accelerating the pace towards true behavior change.

4. Layer Brand Storytelling Across the Connected Journey

A tighter link with brand storytelling will give newly empowered MCM teams a considerable edge over those who try to build brands in traditional ways. Brand storytelling needs to capitalize on the revamped MCM toolset – one that guides customers to immerse in newly combined digital / virtual reality, but also keeps them focused on the behavioral goals that lead to better outcomes. Whether it’s completing a hospital procedure or starting and staying on a potentially costly prescription medication, brand stories are essential to guiding desired behavior. The future of customer care is about caring for people and people feeling cared for. When measuring healthcare outcomes, high customer motivation scores correlate to a positive mental attitude. Brands must be evaluated on the softer scores that indicate behavior change alongside the hard metrics that indicate engagement.

Connected Journeys Will Define What Good MCM Looks Like

Given changing media consumption behavior and the rise of addressability, brands will be increasingly built in the addressable mid-funnel, giving multi-channel marketing powered by connected journeys a resurgence in 2016. 2016 will require a healthy dose of ideation, but shifting to a customer-driven world where real-time segment needs drive more dynamic planning cycles will accelerate change and speed to volume for most brands. Going forward into 2016, if we expect to fundamentally change the way we go to market, we all need to get better putting the customer at the center of the planning process to illustrate the ideal experience, then align the teams, tools, and talent to push ahead further and faster in the individual conversations that will drive brand success going forward.